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The immunomodulatory activity of diterpene alkaloids from Aconitum lycoctonum L. (Ranunculaceae family) was evaluated; the 
alkaloid components were extracted from plants grown wild in the Apennines near Parma (Northern Italy). The diterpene alkaloid 
lycoctonine - evaluated by means of HPLC and IR techniques - reaches its highest value in flowers, followed by stems, roots and leaves, 
while the maximal value of aconitine alkaloid is in leaves and stems. Aconitine content is not quantifiable in the hypogean apparatus; on 
the contrary, in the leaves aconitine exceeds the lycoctonine amount. In order to evaluate the immonomodulatory activity of the alkaloid 
fraction, a rapid and sensitive two-color flow cytometric method for simultaneous measurement of phagocytosis rate was performed. 
Phagocytosis was determined by the measurement of internalized Candida albicans by leukocytes (monocytes and granulocytes). The 
enhancement of phagocytosi on peripheral polymorphonuclear leukocytes a 7% increase, znd on monocytes statistically significative 
(**P<0.001). A. lycoctonum alkaloid extract had an immunomodulatory activity very similar to that reported for other Aconitum species 
from Asia..  




The species belonging to the Aconitum L. genus 
(Ranunculaceae family) are more known for their toxicity, 
due to the presence of diterpene alkaloids, such as 
aconitine, than for their therapeutic properties [1]. In 
Eastern countries, especially in China, Aconitum plants are 
opportunely treated and included in many pharmaceutical 
preparations also with immunomodulatory activity. The 
Aconitum sp. extracts, namely A. carmichaelii, are 
prescribed to stimulate and to increase the 
immunomodulatory capacity [2-7]. The treatment of 
immunodeficiency conditions is related to different 
situations and foresees the use of many therapeutic 
approaches. The Pharmacopoeias contain many products 
accredited for their potential immunomodulatory effects, 
and prescribed for the treatment of the forms with moderate 
clinical impact, but which can poorly be treated 
pharmacologically. 
The panorama of the natural products with potential 
immunomodulatory activity is variegated and still 
discussed. On the basis of the literature data, these products 
can be divided into two categories: products with high 
molecular weight such as polysaccharides, e.g. from 
Echinacea purpurea (L.) Moench. and other Echinacea 
species, from Astragalus mongholicus Bunge, and products 
with low molecular weight, e.g. diterpene alkaloids and 
norditerpene alkaloids [8-13] and essential oils, e.g. from 
mint [14, 15].  A general review on the matter has been 
proposed which brought the role played by the natural 
extracts in this field again to the foreground [16].  
The aim of this study was (I) to analyse the alkaloid 
components in Aconitum lycoctonum L. for which valid 
literature references were missing and (II) to evaluate if and 
how the extracted alkaloids could have immunomodulatory 
activity evaluated as phagocytosis on whole blood of 
healthy individuals (donors). 
 
MATERIALS AND METHODS 
Plant Material. Aconitum lycoctonum L. was collected in 
Lagoni place (Parma province), 1300 m. a.s.l., in the 
Apennines mountains, Northern Italy, along a stream 
mountain. After collection, the plants were separated in 
different parts: old and young root-tubers, thin secondary 
roots, stalks, leaves and flowers. 
The qualitative and quantitative content (% dry weight 
d.w.) of diterpene alkaloids was analysed in the fresh plants 
and then the extracts were stored at –20°C. 
Extraction of diterpene alkaloids. The adopted method 
was previously described [17]. Briefly: the plant tissue (in 
duplicate), thinly minced, extracted with HCl 0.1 N (1:10 
w/v), 1 h, r.t., was re-extracted with HCl 0.1 N (1:10 w/v), 
r.t., 24 h. The acidulated watery phases were collected and 
extracted (1:1 v/v) with CHCl3 x 3. The addition of KCl 0.1 
N inhibits the developing of emulsions. The chloroform 
layer, dehydrated on anhydrous sodium sulphate, was 
reduced in volume under vacuum (40°C), and then stored at 
4°C.  
Diterpene alkaloid HPLC analysis. Alkaloids are 
monitored by High Performance Liquid Chromatography 
(HPLC), reversed phase. For the quantitative analysis the 
internal standard technique was used. The compound more 
suitable as internal standard was 1-chloro-2,4-di-
nitrobenzene: its peak was shown in an area without peaks 
referring to other compounds, which could interfere in the 
analytical determination. HPLC chromatographic system 
was a Jasco instrument, equipped with a detector: UV – 
975 Intelligent UV/VIS Detector; pump PU-980 Intelligent 
HPLC Pump; injection valve manual, Rheodyne mod. 7725 
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Catati, California; column LC-8 SupelcoSIL 25 cm x 4 
mm, 5 m. Eluent = water : acetonitrile : 1,4-dioxan (265 : 
150 : 75 v/v) + HClO4 0.01 M, to pH = 2.6 with NH4OH at 
10%. Injection volume: 5 l; flow rate 1 ml/min; detection 
 = 235 nm. 
Isolation and Determination of Lycoctonine. For the 
identification of the compound tentatively referred to 
lycoctonine, the root alkaloid extract was repeatedly 
chromatographed by means of RP-HPLC. An amount 78 
g of a compound with a high purity degree (89% control 
HPLC) was obtained. The isolated compound was basified 
(NaOH 0.1 N at pH = 10), afterwards the compound, as 
base, was re-extracted with chloroform (1:1 v/v) in watery 
phase; the organic phase was separated and concentrated. 
The purified compound, dissolved in dichloromethane, was 
evaporated on a NaCl disk for the analysis at the IR-
spectrometer Perkin Elmer FT-IR 1710. After identification 
of the molecule understudy, an amount of lycoctonine 
adequate to prepare a calibration curve was isolated. The 
quantitative analysis of lycoctonine was then carried out 
with the external standard method. 
Immunomodulatory Tests – Preparation of Blood 
Samples. Human leukocytes were obtained from 
heparinized whole blood samples of healthy donors by the 
Transfusion Centre of the Monza Hospital, Italy. The 
samples were kept at r.t. and used within 2 hours. A 
complete count of the hemochromocytometric leukocyte 
formula for each sample was performed (Roche Cobas 
Argos). The blood polymorphonuclear cell value was used 
to define the appropriate ratio between phagocyting cells 
and the pabulum of particles to be ingested (Candida 
albicans). An analogous calculation was performed for 
monocytes. 
Preparation of Candida albicans blastospores. For the 
preparation of the fluorescent spores of Candida albicans 
we used the method described by Saresella [18, 19]. 
Candida albicans was maintained in liquid culture in 
Sabouraud medium containing 2% dextrose (DIFCO, 
Detroit, USA) at 37°C for 18-24 h. The blastospores were 
then washed three times and re-suspended in phosphate-
buffered-saline (PBS), pH 7.2. The vitality of the 
blastospores after the washings was evaluated with the 
trypan blue exclusion method, and has to be higher than 
90%. For the phagocytosis test the blastospores of Candida 
albicans were fixed in 70% ethanol for 1 hour and then 
washed two times in PBS. The fixed blastospores were 
labelled with fluorescein isothiocyanate (FITC) (Sigma 
Aldrich, Milan, Italy) at 0.01 mg/ml in a solution of 
carbonate/bicarbonate 0.5M (pH 9.5), 30 min, r.t., under 
agitation, in the dark. The labelled blastospores were 
washed 2 times in PBS and kept in aliquots of ca. 10 
millions/ 200 l and stored at –80°C. 
Phagocytosis Test. The phagocytosis experiments in flow 
cytometry were carried out at the Laboratory Operative 
Unit Kidney Transplant, Niguarda Ca' Granda Hospital, 
Milan, Italy. 
The treated leukocytes were monitored by a flow cytometer 
FACSCalibur Becton Dickinson (San Josè, CA, USA) 
equipped with a laser source with argon ion emitting at  = 
488 nm and sensors for cell diameter (Forward Scatter, 
FSC), complexity (Side Scatter, SSC). The green 
fluorescence of FITC C. albicans was detected at  = 530 
nm (FL1), while the orange fluorescence of C. albicans 
further treated with ethidium bromide EtBr was detected at 
 = 575 nm (FL2). An appropriate compensation net of the 
two fluorescence emissions is pre-set, as well as a reading 
configuration with priority and acquisition limit on the 
FSC. The events (10,000 cells) were acquired and during 
the analysis a selection "gate" of the granulocytic or 
monocyte populations was designed, in relation to the 
different dimensions of the leukocyte populations. Figure 1 
summarises the qualitative parameters and schematizes the 
four different groupings in which the blood cells split up 
after the contact with FITC-Candida. The lower right 
quadrant (LR) contains PMN having only ingested Candida 
(FITC+ EB-). The intensity of the mean fluorescence is 
proportional to the mean number of ingested particles per 
leukocyte. The upper right quadrant (UR) includes the cells 
which can have both ingested and adhered Candida 
albicans. The extracellular position of Candida + FITC 
gives to the particle both the maintenance of the original 
colouring with FITC and the acquisition of ethidium 
bromide, added immediately before the reading. The 
populations which did not interact with Candida albicans 
are included in the lower left quadrant (LL). In the upper 
left quadrant (UL) the dead cells are grouped, they assumed 
a red/orange fluorescence of ethidium bromide which 




Qualitative parameters and scheme of the four different 
groupings in which the blood cells split up after the contact 
with FITC-Candida (UL, UR, LL, LR, se details in the 
test). 
 
Statistical analysis. All data are expressed as mean ± SD. 
The t-test compares the actual difference between two 
means in relation to the variation in the data (expressed as 
the standard deviation of the difference between the 
means). The following quantitative data statistically 
elaborated are collected for each cell population, as 
reported in Fig. 2: 
1) percentage of elements with only internalised 
Candida albicans (FITC+ EB-) [LR quadrant] 
2) percentage of elements with both internalised and 
adhered Candida albicans (FITC+ EB+) [UR 
quadrant] 
3) sum of the percentages of points 1 and 2 (total of 
the elements interacting with Candida albicans) 
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4) normalisation of percentage 1 on the total of 
interacting elements  
5) normalisation of percentage 2 on the total of 
interacting elements  
 
Figure 2 
Example of the source of numerical data from flow 
cytometer and statistical elaboration 
 
RESULTS 
Botanical Aspects. The yellow-flowered monkshood 
Aconitum lycoctonum s.l. (Ranunculaceae) is a perennial 
herb, collected in full anthesis at the end of July, at 1300 
m.a.s.l. in the Parma Apennines, along the banks of a 
mountain river, a characteristic habitat for many species of 
the Aconitum genus. Aconitum lycoctonum occurs from the 
lowlands to the subalpine zone and is found mainly in 
forests and other shady habitats [21].  
The investigated population belongs to the species 
Aconitum lycoctonum L., according to different Authors 
[22-25]. Due to high morphological variability across its 
range in Southern and Central Europe, many taxa of 
uncertain taxonomic rank have been described.  On the 
basis of these arguments, some Authors considered A. 
lycoctonum like a group in which the speciation has been 
developed [26]. A. lycoctonum could include forms which 
gradually pass one into the other, trespassing on the more 
neighbouring species characterised by the yellow flower, as 
A. vulparia Reichb. and A. lamarkii Reichb. [27].  
Phytochemical Investigation. A.lycoctonum alkaloids 
were analyzed by RP-HPLC. The main alkaloid – 
lycoctonine – a known compound, not available as 
authentic standard was obtained in pure form by repeated 
HPLC separation and identified by IR technique. The 
structural identity of the recovered lycoctonine was defined 
through comparison with aconitine structure, the only 
diterpene alkaloid available as authentic standard. At 3497 
cm^-1 the signal of the alcoholic OH-group, located on the 
ring with six carbon atoms. The signals of the –CH2-
bindings are in the zone comprised between 2800 and 3000 
cm^-1. The signal of the carbonyl of the esters, which the 
aconitin base forms with acetic acid and benzoic acid, is 
clear at 1718 cm^-1. The signal of the –C-O-C and –C-N-
C- bindings is reported at 1279 cm^-1. The signals of the –
O-CH3-radicals (ether group) are evident at 1122-1097 
cm^-1. The signal of water (traces) is visible at 3400 cm^-1 
(approximately): it is characteristic due to the rounded 
peak. Both aconitine and lycoctonine are two diterpene 
alkaloids with a skeleton similar to C-19. They differ in the 
substitutions in C-7: in aconitine this position is never 
oxygenated, while it is always oxygenated in lycoctonine. 
The IR-spectrum of licoctonine isolated from the plant is 
however altered by some "impurity" (signals between 2800 
and 3000 cm^-1), which is attributable to lipidic chains 
(presence of –CH2- bindings). The other signal regarding 
the presence of a lipid is the binding of the carbonyl of the 
fatty acid ester (1713-1733 cm^-1). The signal due to the –
O-CH3 group (ether group) is noted at 1122 cm^-1, which 
is available in four units on the lycoctonine molecule. The 
signal corresponding to 1200 cm^-1 (approximately) has to 
be correlated to the presence of the –C-O-C- and –C-N-C- 
bindings. The spectrum of the isolated compound, 
compared to that of aconitine, used as reference, is 
referable to that of lycoctonine esterified in at least one 
position by a fatty acid. Lipoalkaloids deriving from 
diterpene alkaloids had already been identified in other 
species belonging to the Aconitum genus [28 - 31]. 
After lycoctonine isolation and structural identification, the 
quantitative analysis of the alkaloids was performed. 
Lycoctonine reaches its highest value in flowers, followed 
by stems, roots and leaves, while the maximal value of 
aconitine is in leaves and stems. Aconitine content is not 
quantifiable in the hypogean apparatus; on the contrary, in 
the leaves aconitine exceeds the lycoctonine amount  
(Fig. 3).  
 
Figure 3 
Alkaloid content(lycoctonine and aconitine) in 
A.lycoctonum different parts 
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Panel A                                                                              Panel B 
 
Figure 4 – Panel A and Panel B 
Increase of phagocytosis (7%) by PMN (Panel a) and by monocytes (Panel B) 
 
Immunomodulatory activity. This phagocytosis test is 
based on the measurement of the ingestion of fluorescent 
Candida albicans cells in a predefined quantitative ratio 
with the effector leukocytes (monocytes and granulocytes), 
in whole blood, with the addition of a system to detect the 
true ingestion of Candida albicans by the leukocytes, 
distinguishing it from the adhesion phenomenon.  
Fluorescein isothiocyanate (FITC) is widely used to attach 
a fluorescent label to proteins via the amine group. The 
isothiocyanate group reacts with amino terminal and 
primary amines in proteins. It is used for the labeling of 
proteins including Candida cells, antibodies, lectins, etc. 
Ethidium bromide is a well-known and widely used 
fluorescent dye in biotechnology research. It used in a 
number of fluorimetric assays for nucleic acids  
The coupling colouring of fluorescein and ethidium 
bromide allows to state the true ingestion or adhesion cells. 
Fluorescein isothiocyanate is cleaved by diesterase in live 
cells to fluorescent molecule fluorescein, while ethidium 
bromide passes through the membranes of dead cells and 
bind to nucleic acid, staining the cell nuclei red. It is a 
mutagenic compound which intercalates double-stranded 
DNA and RNA. 
The definitive results refer to a series of conclusive 
experiments (11 performed in duplicate), in which the 
definitive method was applied, deriving from the 
preliminary optimisation process of the method: 
concentration of extract 0.1 g/l, incubation 1 h, use of a 
blocking solution of the phagocytosis, storage of the 
sample in ice, standardised timing. The distinction between 
internalized and/or attached and/or internalized Candida 
cells was done via quenching of FITC-fluorescence by 
ethidium bromide. We analysed the effects on total 
phagocytosis, on the percentage of cells with only 
internalised Candida albicans (phagocyted), on the 
percentage of cells with Candida albicans both adhered and 
internalised, both by the granulocytes and the monocytes 
present in the same blood sample and identified with the 
flow cytometer using different "gate". The extracts show on 
the average a more marked effect on the percentage of 
monocytes with internalised Candida albicans. From the 
whole of the investigations, we can state that the 
immunomodulatory activity was manifested in an increase 
of phagocytosis (7%) by the polymorphonuclear 
granulocytes (PMN). A statistically significant increase 
(**P<0.01) was obtained by the monocytes treated with the 
alkaloids of A. lycoctonum (Fig. 4, panel A and B). 
Cell samples examined by flow cytometry, allowing rapid 
and kinetic assessment of large numbers of cells and 
subsets of Candida-exposed cells. This procedure provides 
a simple and effective method to distinguish surface-bound 
from internalized C.albicans, and allows precise kinetic 
analyses on large numbers of cells. 
 
CONCLUSIONS 
Plants belonging to the Aconitum genus are arousing 
renewed interest for the promising biological activities of 
its alkaloids. A. lycoctonum was previously investigated for 
the identification of alkaloids structurally correlated to 
lycoctonine [32]. In the population under study we even 
identified aconitine, a typical alkaloid of A. napellus and 
usually not mentioned for A. lycoctonum. 
As regards the results of the biological activity, the 
phagocytosis, a major mechanism used in the immune 
system to remove pathogens, was evaluated. Phagocytosis 
is the first step of defense against infections from the innate 
immune system and the phagocytic efficiency is considered 
the response of the innate (non specific) immune system. In 
this work, phagocytosis was determined by the 
measurement of internalized Candida albicans by 
leukocytes (monocytes and granulocytes). C.albicans is the 
major fungal component of the normal microflora of the 
healthy host. However, when immune defenses are 
compromised, Candida transforms itself into an 
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opportunistic pathogenic killer [33]. The binding of 
C.albicans to the surface of leukocytes and/or the 
internalization of C.albicans by all or a subset of cells are 
key points in the phagocytosis process. The current studies 
establishes a method for the discrimination of surface-
bound from internalized C.albicans. A flow cytometric 
technique was then adapted for study of C.albicans – 
leukocytes interactions, with addition of ethidium bromide 
to quench green fluorescence associated with FITC-labeled  
C.albicans that was cell-bound but remained external. 
Ethidium bromide was excluded by intact cell membranes, 
and internalized C.albicans retained green fluorescence. 
The increase in phagocytosis by human monocytes and 
polymorphonuclear elements, after administration of 
diterpene alkaloids, confirms the immunomodulatory 
activity attributed to the Aconitum extracts [34].  
According to literature data, in which an 
immunostimulatory activity was evaluated in rats treated 
with benzoylmesaconine (alkaloid obtained by partial 
hydrolysis of mesaconitine, losing the acetic acid moiety) 
[35], our experiments show an enhanced phagocytosis of 
Candida albicans by human granulocytes (7-8%) and 
monocytes (**P<0.001), in presence of Aconitum 
lycoctonum alkaloids. 
In summary, the results of the present study show that 
diterpene alkaloids from Aconitum lycoctonum L. may 
affect the functional responses of human PMNs and 
monocytes. As information regarding the 
immunomodulatory properties of aconite are still very 
limited, our results encourage more extensive studies to 
assess the potential of monkshood alkaloids and of 
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